248 related articles for article (PubMed ID: 15642993)
1. Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay.
Mahler M; Stinton LM; Fritzler MJ
Clin Diagn Lab Immunol; 2005 Jan; 12(1):107-13. PubMed ID: 15642993
[TBL] [Abstract][Full Text] [Related]
2. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
Mahler M; Fritzler MJ; Blüthner M
Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
4. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.
Mahler M; Waka A; Hiepe F; Fritzler MJ
Arthritis Res Ther; 2007; 9(4):R68. PubMed ID: 17640359
[TBL] [Abstract][Full Text] [Related]
5. Anti-Sm and anti-RNP antibodies.
Migliorini P; Baldini C; Rocchi V; Bombardieri S
Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
[TBL] [Abstract][Full Text] [Related]
6. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
8. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
[TBL] [Abstract][Full Text] [Related]
10. Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83-119 peptide in systemic lupus erythematosus and other autoimmune diseases.
Jaekel HP; Klopsch T; Benkenstein B; Grobe N; Baldauf A; Schoessler W; Werle E
J Autoimmun; 2001 Dec; 17(4):347-54. PubMed ID: 11771960
[TBL] [Abstract][Full Text] [Related]
11. [Enzyme immunoassay for the detection of autoantibodies to nRNP and Sm: a rapid and sensitive alternative to current procedures].
Blazek M; Naser W; Bayer-Beck J; Lakomek HJ; Werle E; Fiehn W
Z Rheumatol; 1992; 51(2):87-93. PubMed ID: 1615735
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
[TBL] [Abstract][Full Text] [Related]
14. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
Albon S; Bunn C; Swana G; Karim Y
J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
16. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to the Sm antigen: immunological approach to clinical aspects of systemic lupus erythematosus.
Homma M; Mimori T; Takeda Y; Akama H; Yoshida T; Ogasawara T; Akizuki M
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():188-93. PubMed ID: 2441045
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
20. Mapping of epitopes on the SmD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus.
Sabbatini A; Dolcher MP; Marchini B; Bombardieri S; Migliorini P
J Rheumatol; 1993 Oct; 20(10):1679-83. PubMed ID: 7507527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]